StockData
Illumina, Inc. logo

Illumina, Inc. (ILMN) stock

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3013% above fair value
$210.01+7.40 (+3.65%)

Close on Nov 18, 2026Market cap $31.75BP/E 36.0Yield –

Illumina operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Illumina's operating income for the twelve months ending Sep 27, 2026 was $960.00M, up 23.1% year over year. For fiscal 2025 it was $807.00M. Over ten years it grew 2.8% a year on average. The highest annual figure on record is $985.00M in fiscal 2019.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 28, 2025$807.00M–
FY2024Dec 29, 2024-$833.00M–
FY2023Dec 31, 2023-$1.07B–
FY2022Jan 1, 2023-$4.18B–
FY2021Jan 2, 2022-$123.00M-121.2%
FY2020Jan 3, 2021$580.00M-41.1%
FY2019Dec 29, 2019$985.00M+11.6%
FY2018Dec 30, 2018$883.00M+45.7%
FY2017Dec 31, 2017$606.00M+3.2%
FY2016Jan 1, 2017$587.00M-4.2%
FY2015Jan 3, 2016$613.00M+19.1%
FY2014Dec 28, 2014$514.71M+283.8%
FY2013Dec 29, 2013$134.11M-33.2%
FY2012Dec 30, 2012$200.75M+0.6%
FY2011Jan 1, 2012$199.46M-5.8%
FY2010Jan 2, 2011$211.65M+68.5%
FY2009Jan 3, 2010$125.60M+56.1%
FY2008Dec 28, 2008$80.46M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$305.00M+34.4%
Q2 FY2026Jun 28, 2026$245.00M+14.5%
Q1 FY2026Mar 29, 2026$209.00M+27.4%
Q4 FY2025Dec 28, 2025$201.00M+14.9%
Q3 FY2025Sep 28, 2025$227.00M-69.4%
Q2 FY2025Jun 29, 2025$214.00M–
Q1 FY2025Mar 30, 2025$164.00M–
Q4 FY2024Dec 29, 2024$175.00M–
Q3 FY2024Sep 29, 2024$741.00M–
Q2 FY2024Jun 30, 2024-$1.64B–
Q1 FY2024Mar 31, 2024-$111.00M–
Q4 FY2023Dec 31, 2023-$164.00M–
Q3 FY2023Oct 1, 2023-$754.00M–
Q2 FY2023Jul 2, 2023-$88.00M–
Q1 FY2023Apr 2, 2023-$64.00M-134.8%
Q4 FY2022Jan 1, 2023-$127.00M-409.8%
Q3 FY2022Oct 2, 2022-$3.66B–
Q2 FY2022Jul 3, 2022-$579.00M-409.6%
Q1 FY2022Apr 3, 2022$184.00M-4.7%
Q4 FY2021Jan 2, 2022$41.00M-69.2%
Q3 FY2021Oct 3, 2021-$545.00M-436.4%
Q2 FY2021Jul 4, 2021$187.00M+94.8%
Q1 FY2021Apr 4, 2021$193.00M+2.1%
Q4 FY2020Jan 3, 2021$133.00M-50.4%
Q3 FY2020Sep 27, 2020$162.00M-47.4%
Q2 FY2020Jun 28, 2020$96.00M-53.2%
Q1 FY2020Mar 29, 2020$189.00M-7.4%
Q4 FY2019Dec 29, 2019$268.00M+36.0%
Q3 FY2019Sep 29, 2019$308.00M+27.8%
Q2 FY2019Jun 30, 2019$205.00M-9.7%
Q1 FY2019Mar 31, 2019$204.00M-6.4%
Q4 FY2018Dec 30, 2018$197.00M-14.3%
Q3 FY2018Sep 30, 2018$241.00M+33.1%
Q2 FY2018Jul 1, 2018$227.00M+58.7%
Q1 FY2018Apr 1, 2018$218.00M+319.2%
Q4 FY2017Dec 31, 2017$230.00M+60.8%
Q3 FY2017Oct 1, 2017$181.00M–
Q2 FY2017Jul 2, 2017$143.00M–
Q1 FY2017Apr 2, 2017$52.00M–
Q4 FY2016Jan 1, 2017$143.00M–

More Illumina figures

See a number that looks wrong?